Luciferase reporter assays are highly versatile, but their true power comes when the reporter system youโve selected is well aligned with your experimental objectives. Whether you’re tracking transcriptional changes or pathway activity, assessing miRNA/siRNA regulation, or using as a readout in CRISPR-based screens, choosing a reporter and detection assay format that fit your specific research goal is critical for meaningful, reproducible results.
You may have already read about how to choose a luciferase reporter assay, but now, we will walk through how to match luciferase reporter systemsโreporter types, detection chemistries, and formatsโto your specific experimental needs. While luciferases like NanoLuc have applications beyond gene expression, this blog focuses on genetic reporter applications and the workflows that support them.
G-protein-coupled receptors (GPCRs) are among the most important drug targets in human biology, mediating signals across nearly every physiological system. But not all GPCRs are equally easy to studyโespecially those that interact with peptide ligands. These ligands tend to be flexible, fast-moving, and hard to trace in live cells by standard methods. Historically, radioligand binding assays have filled this gap, offering a way to measure peptideโreceptor interactions with high sensitivity. However, these assays are typically performed using isolated membrane preparations or cells under non-physiological conditions, and they donโt allow for real-time or kinetic measurements.
As SARS-CoV-2 continues to evolve, one lesson is painfully clear: immunity today may not guarantee protection tomorrow. Viruses are experts at mutating into countless variants to evade detection or neutralization by the immune system. In the race to keep up with this “immune escape”, researchers have largely focused on reactive strategiesโtesting vaccines against variants that already exist. But what if we could flip the script and anticipate where the virus is going next?
Thatโs precisely the aim of a new study published in Immunity.ย This study introducesย EVE-Vax, a computational design platform that builds synthetic spike proteins capable of mimicking immune escape mutationsโbefore they naturally arise.
MacKenzie Gartner, Lead Technologist at DCi, operates a Maxwellยฎ instrument.
For twenty years, the transplant lab at Dialysis Clinic, Inc. (DCi) in Nashville, TN has depended on Maxwell instruments for their automated nucleic acid purification. In fact, the lab was the first to purchase the instrument when it debuted in 2005. Today, theyโve scaled up to three of the latest Maxwellยฎ Instruments.
โTheyโre great little instruments,โ says Christina Sholar, Clinical Supervisor at DCi. โI think this is our third generation, and we still have the original in the basement. We love them.โ
Christinaโs lab runs critical tests to ensure compatibility between donors and recipients for solid organ and stem cell transplants. With precious samples and urgent demands, they need tools they can depend on for high-quality results. Their Maxwellยฎ instruments help them ensure successful downstream analysis to support important clinical decisions.
Precious Samples, Urgent Timelines
Hailey, a technician at DCi, loads a Maxwellยฎ cartridge.
Founded in 1971 as a non-profit dialysis clinic, DCi now supports a broad spectrum of kidney health issues, including transplants. The company has also expanded its operations to support organ transplants through federally designated organ procurement organizations. Christinaโs lab runs the tests to ensure compatibility between donors and recipients.
โWe cover the state of Tennessee,โ Christina says. โWe do the typing and antibody analysis for solid organ transplants, and then we follow them post-transplant to see if theyโve developed antibodies to the donor. We also do stem cell workups and follow-ups.โ
The lab processes 150-200 samples per week. In addition to managing the high sample throughput, the team also must be available 24/7 for urgent calls when an organ donor passes away.
โWe used to average about 50 donors a month, but thatโs creeping up,โ Christina says.
Christina says her team needs a workflow built for speed and minimal hands-on processing. With downstream assays including NGS and qPCR, they also need to trust theyโll have a high-quality DNA sample to work with. Thatโs what led them to the Maxwell platform in 2005.
Instrumentation for Easy, Reliable Results
โMaxwell purifications are an easy thing to start new employees with, because they can get quality DNA very easily,โ says MacKenzie Gartner, Lead Technologist in Christinaโs lab at DCi. โTechs pick up on it very quickly, and itโs something they can feel confident in doing by themselves.โ
Twenty years ago, the lab was using manual methods to purify all their nucleic acids. Unlike MacKenzie, Christina remembers those days and admits they werenโt fun. The protocols were labor-intensive, and much more prone to human error. Now, they donโt even teach manual methods anymore.
The DCi lab currently operates three Maxwellยฎ instruments.
โWhen I came on nine years ago, they were teaching a manual method as backup for the Maxwell instruments, but they never got around teaching it to me because it was needed so rarely,โ MacKenzie says. โNow itโs not even in the training materials.โ
MacKenzie works hands-on with the Maxwell instruments almost every day. The lab mainly uses the Maxwellยฎ Buffy Coat DNA Kit and Maxwellยฎ Buccal Swab DNA Kit. Buccal swabs require 20 minutes of passive pre-processing, but buffy coats can be added directly to the Maxwell cartridges. From there, the automated protocol is only 45 minutes.
โItโs nice that both of them can be run on the same instrument, which gives us flexibility knowing that all three instruments can be available no matter what weโre doing,โ MacKenzie adds.
One of the lab’s original Maxwellยฎ instruments, still in storage in the basement.
Christina says the Maxwell instruments provide much cleaner DNA eluates than their past manual methods. This is invaluable for lab efficiency, but itโs even more important with stem cell testing.
โWith stem cells, they may only send one tube but want three or four different tests,โ she explains. โWe donโt have room for error โ those samples are precious.โ
โWe keep the instruments pretty active,โ MacKenzie adds. โThat room constantly has their little noises going. But theyโre so dependable โ they donโt take much maintenance, and we can count on having one available even when we get some urgent samples from a donor.โ
Long-Term Partnership for Success
โPromega is probably our favorite company to work with, as far as support goes,โ Christina says. โWe rarely have issues, but when we do, we get great responses very quickly.โ
As a leader, Christina values strong relationships with her suppliers. Though the labโs sales representative has changed a few times over the past two decades, she says each one has been reliable and helpful in keeping the lab operations running smoothly. The lab has also benefited from regularly scheduled preventive maintenance visits from Promega service engineers.
โOverall, I just love how dependable the instruments are,โ Christina says. โWeโre using them all the time. Theyโre truly our workhorses.โ
This blog was written in collaboration with Tian Yang, Associate Product Manager at Promega.
Cancer is often driven not only by genetic mutations, but by changes in how genes are turned on or offโepigenetic alterations. Two key players in this space are bromodomain and extra-terminal (BET) proteins and histone deacetylases (HDACs).
BET proteins help activate gene expression by recognizing acetylated lysines on histones, while HDACs remove these acetyl groups, repressing transcription. When these mechanisms become dysregulated, they can promote tumor growth or silence tumor suppressors.
To counteract this dysregulation, researchers have developed inhibitors that target BET proteins and HDACs. While combinations of these drugs have shown synergy, using two separate compounds introduces challenges with dosing, toxicity and pharmacokinetics. Recent efforts have focused on designing multitarget inhibitorsโsingle molecules that can simultaneously block BET and HDAC activity.
RT-qPCR (reverse transcription quantitative PCR) is a powerful technique for quantifying RNA expressionโbut it doesnโt always cooperate. Even when youโve followed the protocol carefully, unexpected results can appear: flat curves, unexpected Cq values, or inconsistent replicates. When that happens, youโre left wondering… what went wrong?
In this blog, weโll walk through five key questions to help you troubleshoot RT-qPCR issues with confidence. From common errors to more stubborn challenges, weโll also explore what to consider when technique isnโt fully the problemโand when it might be time to rethink your reagents.
This guest blog post is written by Tian Yang, Associate Product Manager at Promega.
There are often challenges with translating results from a test tube into a living system, demanding more physiologically relevant assays. In drug discovery, demonstrating a compoundโs ability to modulate its target protein in live cells is a critical step in the hit-to-lead workflow. A variety of cell-based assays can be used to assess a compoundโs activity in live cells. Take kinase inhibitors as an example, these assays can range from substrate phosphorylation assays that more directly report on the activity of target kinases, to genetic reporter assays or cell viability assays that assess the downstream effects of target modulation.
In the case of Tivantinib, several pieces of data from its development were used to establish its role as an inhibitor of MET kinase. MET Kinase is a prominent target for anti-cancer therapeutics due to frequent MET dysregulation in a wide range of tumors. For example, over-activation of MET drives cancer proliferation and metastasis. In the initial report on Tivantinib, in addition to biochemical activity assays performed with purified MET, the activity of Tivantinib in cells was verified by several methods, including: 1) inhibition of phosphorylation of MET and downstream signaling pathways, 2) cytotoxicity in cancer cell lines expressing MET, and 3) antitumor activity in xenograft mouse models (1). Additionally, a co-crystal structure of the MET-Tivantinib complex was solved, seemingly confirming that Tivantinib is a bona fide MET inhibitor capable of engaging MET in live cells (2). Based on these observations and other pre-clinical data, Tivantinib appeared to be a promising drug candidate and was taken through phase 3 clinical trials targeting cancers with MET overexpression. However, Tivantinib ultimately was not approved as a new therapeutic, failing to show efficacy in these phase 3 clinical trials (3,4).
Within three years of the initial publication on Tivantinib, two separate articles challenged the mechanism of action in Tivantinib-induced cytotoxicity of tumor cells (5,6). Authors for both articles showed that Tivantinib can kill both MET-addicted and nonaddicted cells with similar potency. Both articles also concluded that perturbation of microtubule dynamics, instead of MET inhibition, is likely responsible for the cytotoxicity observed with Tivantinib. Considering the failed clinical trials and uncertainties regarding the mechanism of action, one may wonder if the original pre-clinical work adequately determined if Tivantinib effectively binds and inhibits MET in cells? If Tivantinibโs cellular engagement to MET was assessed directly rather than by MET phosphorylation analysis, would a different pre-clinical recommendation have been made?
The weather is warming up (at least in the Northern Hemisphere). There is nothing more refreshing on a hot summer day than a dip in cool lake waters, so people everywhere are digging out their swimsuits and hitting the beach. Unfortunately, the same warm temperatures that drive us to the beach can also cause a potentially deadly overgrowth of blue-green algae โalso called harmful algal blooms (HABs)โin the water of our favorite pond or lake.
Researchers from Wenzhou Medical University in China have identified a mechanism involving long non-coding RNAs (lncRNA) that contributes to colorectal cancer (CRC) progression. CRC is the third most common cancer worldwide and is one of the most lethal cancers across the globe. Understanding the molecular mechanisms that underlie the development and progression of CRC is critical to developing biomarkers to detect it and new therapeutics to treat it.ย
Each week, thousands of parcels are shipped to customers from Kepler Center in Madison, WI.
Weโre all used to the convenience of online ordering, whether itโs a last-minute birthday gift or a phone charger delivered overnight. That same ease and speed is what scientists expect when ordering critical reagents for their work. At Promega, we get that. Thatโs why we pledge: Youโll get what you need, when you need it.
For customers in the United States, any order received by 4:00 pm will be delivered the next day. We measure our success in honoring this pledge using a metric called โorder fill rate.โ Our global order fill rate is consistently above our benchmark of 94.5%, sometimes passing 98%.
But how does that actually happen? With thousands of orders leaving our warehouse every week, it takes more than just good intentions. Here’s a look behind the scenes at how our teams deliver on that promise.
XWe use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we wonโt set them unless you accept them. To learn more about our approach to Privacy we invite you to Read More
By clicking โAccept Allโ, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we wonโt set them unless you accept them. To find out more about cookies and how to manage cookies, read ourย Cookie Policy.
If you are located in the EEA, the United Kingdom, or Switzerland, you can change your settings at any time by clickingย Manage Cookie Consentย in the footer of our website.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-advertisement
1 year
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
gdpr_status
6 months 2 days
This cookie is set by the provider Media.net. This cookie is used to check the status whether the user has accepted the cookie consent box. It also helps in not showing the cookie consent box upon re-entry to the website.
lang
This cookie is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Cookie
Duration
Description
SC_ANALYTICS_GLOBAL_COOKIE
10 years
This cookie is associated with Sitecore content and personalization. This cookie is used to identify the repeat visit from a single user. Sitecore will send a persistent session cookie to the web client.
vuid
2 years
This domain of this cookie is owned by Vimeo. This cookie is used by vimeo to collect tracking information. It sets a unique ID to embed videos to the website.
WMF-Last-Access
1 month 18 hours 24 minutes
This cookie is used to calculate unique devices accessing the website.
_ga
2 years
This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gid
1 day
This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visted in an anonymous form.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Cookie
Duration
Description
IDE
1 year 24 days
Used by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
test_cookie
15 minutes
This cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
VISITOR_INFO1_LIVE
5 months 27 days
This cookie is set by Youtube. Used to track the information of the embedded YouTube videos on a website.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Cookie
Duration
Description
YSC
session
This cookies is set by Youtube and is used to track the views of embedded videos.
_gat_UA-62336821-1
1 minute
This is a pattern type cookie set by Google Analytics, where the pattern element on the name contains the unique identity number of the account or website it relates to. It appears to be a variation of the _gat cookie which is used to limit the amount of data recorded by Google on high traffic volume websites.